B) The initial dose of irinotecan classified by UGT1A1 status.
Wild type, n = 28 (%) | Single hetero, n = 26 (%) | P value | |
---|---|---|---|
125 (mg/m2) | 4 (15) | 4 (15) | 1.00 |
150 (mg/m2) | 11 (41) | 9 (35) | 1.00 |
165 (mg/m2) | 12 (44) | 13 (50) | 0.812 |
Abbreviations: Bev, bevacizumab; Ram, ramucirumab; Cmab, cetuximab; Pmab, panitumumab; CPT-11, irinotecan; L-OHP, oxaliplatin.